default author photo

Benjamin Besse

Comité de Pathologies Thoraciques

France

  • Comité de Pathologies Thoraciques

SCHOLARLY PAPERS

5

DOWNLOADS

472

TOTAL CITATIONS

0

Scholarly Papers (5)

Actions:
Email selected abstracts
1.

Weekly Paclitaxel Plus Bevacizumab versus Docetaxel As Second- or Third-Line Treatment in Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC): Results of the IFCT-1103 ULTIMATE Study

Number of pages: 37 Posted: 29 Jun 2019
Alexis Cortot, Clarisse Audigier-Valette, Olivier Molinier, Sylvestre Le Moulec, Fabrice Barlesi, Gerard Zalcman, Patrick Dumont, Damien Pouessel, Claire Poulet, Sandrine Hiret, Adrien Dixmier, Patrick-Aldo Renault, Catherine Becht, Olivier Raffy, Charles Dayen, Julien Mazieres, Eric Pichon, Alexandra Langlais, Franck Morin, Denis Moro-Sibilot and Benjamin Besse
Université de Lille - Thoracic Oncology Department, CHITS Sainte Musse, Centre Hospitalier Général - Le Mans, Bergonié Institute, Aix Marseille Université, Hopital Bichat Claude Bernard, Centre Hospitalier - Chauny, University of Paris - Saint Louis Hospital, Centre Hospitalier Universitaire Lyon Sud, Institut de Cancérologie de l'Ouest, Centre Hospitalier Régional Orleans, Centre Hospitalier - Pau, Clinique de Clémentville, Centre Hospitalier Louis Pasteur, Centre Hospitalier - Saint Quentin, Hôpital Larrey, François Rabelais University - CHU Bretonneau - CHU Hôpitaux De Tours, Intergroupe Francophone de Cancérologie Thoracique, Intergroupe Francophone de Cancérologie Thoracique, CHU Grenoble-Alpes and Comité de Pathologies Thoraciques
Downloads 186 (407,391)

Abstract:

Loading...

NSCLC, paclitaxel, docetaxel, bevacizumab

2.

Infectious Complications in Patients Treated with T-Cell Engager for Solid Tumours or Haematological Malignancies, a Descriptive Study from the REISAMIC Registry

Number of pages: 33 Posted: 12 Nov 2024
Thomas Hueso, Justin Cagnat, Kaïssa Ouali, Mathilde Haberstitch, Benoit Henry, Alina Danu, Camille Bigenwald, Mansouria Merad, Sabine Messayke, Ariane Laparra, Madona Sakkal, Christina Smolenschi, Antoine Hollebecque, Anas Gazzah, Capucine Baldini, Rastislav Bahleda, Benjamin Besse, Charlotte Rigaud, Véronique Minard, Vincent Ribrag, Salim Laghouati, Elisabeth Chachaty, Fabrice Barlesi, Aurélien Marabelle, Olivier Lambotte, Christophe Massard and Jean-Marie Michot
University of Paris-Saclay - Department of Hematology, Gustave Roussy, Gustave Roussy, Gustave Roussy, University of Paris-Saclay - Institut Pasteur, Gustave Roussy - Hematology Department, Gustave Roussy - Hematology Department, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Comité de Pathologies Thoraciques, Université Paris Saclay - Department of Children and Adolescents Oncology, Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Gustave Roussy, Aix Marseille Université, Gustave Roussy, University of Paris-Saclay, Gustave Roussy - Drug Development Department (DITEP) and Gustave Roussy - Drug Development Department (DITEP)
Downloads 114 (621,896)

Abstract:

Loading...

T-cell engager, infections, haematological malignancy, solid tumour

3.

Overall Survival Impact of Pembrolizumab Duration and Comorbidities on Advanced NSCLC: A Nationwide Cohort Study

Number of pages: 37 Posted: 05 Mar 2024
Adrien Rousseau, Stefan Michiels, Julian Bonastre, Alexandre Lolivier, David Planchard, Fabrice Barlesi, Jordi Remon, Pernelle Lavaud, Mihaela Aldea, Maxime Frelaut, Cecile Le Pechoux, Angela Botticella, Antonin Levy, Anas Gazzah, Stéphanie Foulon and Benjamin Besse
Gustave Roussy, University of Paris-Saclay, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Université Paris XI Sud - Institut Gustave Roussy/Gustave Roussy Villejuif, Gustave Roussy, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy and Comité de Pathologies Thoraciques
Downloads 93 (725,554)

Abstract:

Loading...

Pembrolizumab, NSCLC, Cohort, Real-life data, IPTW

4.

Impact of Immunosuppressive Agents on the Management of Immune-Related Adverse Events of Immune Checkpoint Blockers

Number of pages: 20 Posted: 02 Feb 2024
Pierre-Louis CARIOU, Cédric Pobel, Jean-Marie Michot, Francois-Xavier Danlos, Benjamin Besse, Franck Carbonnel, Xavier Mariette, Aurelien Marabelle, Sabine Messayke, Caroline Robert, Emilie Routier, Nicolas Noel and Olivier Lambotte
University of Paris-Saclay, Gustave Roussy, Gustave Roussy - Drug Development Department (DITEP), Gustave Roussy, Comité de Pathologies Thoraciques, University Paris Sud, Université Paris Saclay, Institut d’Hématologie et d’Oncologie Pédiatrique (iHOPe) - Centre Léon Bérard, Gustave Roussy, Gustave Roussy, Gustave Roussy Cancer Campus, University of Paris-Saclay and University of Paris-Saclay
Downloads 48 (1,086,013)

Abstract:

Loading...

immune checkpoint blocker, corticosteroid, immunosuppressant agent, immune-related adverse events

5.

Brief Report: Targeted Therapies and Pancreatic Toxicity in Patients with Lung Cancer, Retrospective Study and Recommendations

Number of pages: 10 Posted: 03 Apr 2024
May-Lucie Meyer, Louis Gros, Natalie Décosterd, Marco Tagliamento, Arianna Marinello, David Planchard, David Combarel, Fabrice Barlesi, Jordi Remon, Benjamin Besse and Mihaela Aldea
affiliation not provided to SSRN, affiliation not provided to SSRN, University of Lausanne - Lausanne University Hospital, Université Paris Saclay - Gustave Roussy Cancer Campus, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Gustave Roussy, Comité de Pathologies Thoraciques and Gustave Roussy
Downloads 31 (1,304,549)

Abstract:

Loading...

Lung cancer, Tyrosine Kinase Inhibitors, Lipase, Amylase, Pancreatitis